Menu

Blog

Apr 14, 2020

CRISPR-Cas9 successfully reverses type 2 diabetes in mice

Posted by in categories: biotech/medical, genetics

Circa 2019


Researchers at Hanyang University, South Korea, have used the gene-editing technology CRISPR-Cas9 to treat obesity and type 2 diabetes in mice, a development that could eventually benefit humans. The therapy specifically reduced fat tissue and reversed obesity-related metabolic disease in the animals.

Comments are closed.